Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
188.06 USD175.77 USD220.39 USD
+92.31%
175.77 USDCurrent price is 92.3% above the base model value.
A
HealthcareDrug Manufacturers - GeneralUnited States
AMGN.US · Amgen Inc.
NMS · US · USD
Latest price338.02 USD
30D+8.86%
Vs. base value+92.3%
Research summary
AMGN.US latest organized financial period shows revenue lacks a complete YoY comparison and net income grew +88.53% YoY. Current price is about 338 USD, while the model base case is about 176 USD; the current price sits +92.3% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue-
Net income8B USD
Free cash flow8B USD
Operating cash flow10B USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:21
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price338.02 USD
Base value175.77 USD
Vs. base+92.3%
Price date2026/04/28
172.93 USD175.77 USD197.77 USD
+92.31%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
172.93 USD188.50 USD197.77 USD
+79.32%
188.50 USDCurrent price is 79.3% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth6.6%
Current price implies roughly 6.6% annualized FCF growth.
6.6%Current price implies roughly 6.6% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
130.86 USD130.86 USD130.86 USD
+158%
130.86 USDCurrent price is 158.3% above the base model value.
Updated: 2026/04/29 07:21
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 10
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | - | 8B USD | 8B USD | 14.23 |
| 2024/12/30 | Annual | - | 4B USD | 10B USD | 7.56 |
| 2023/12/30 | Annual | - | 7B USD | 7B USD | 12.49 |
| 2022/12/30 | Annual | - | 7B USD | 9B USD | 12.11 |
| 2021/12/30 | Annual | - | 6B USD | 8B USD | 10.28 |
Ad placement